HIA
AZN icon

Harbor Investment Advisory’s AstraZeneca AZN Stock Holding History

Harbor Investment Advisory’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$330K Buy
1,766
+262
+17% +$49.3K 0.02% 349
2026
Q1 		$291K Sell
1,504
-266
-15% -$51.3K 0.02% 351
2025
Q4 		$325K Buy
1,770
+77
+5% +$13.5K 0.02% 333
2025
Q3 		$260K Buy
1,693
+109
+7% +$16.5K 0.02% 352
2025
Q2 		$221K Buy
1,584
+67
+4% +$9.39K 0.02% 357
2025
Q1 		$223K Buy
1,517
+184
+14% +$26.6K 0.02% 357
2024
Q4 		$175K Buy
1,333
+356
+36% +$49.8K 0.02% 374
2024
Q3 		$152K Sell
977
-34
-3% -$5.49K 0.02% 378
2024
Q2 		$158K Buy
1,011
+294
+41% +$44.2K 0.02% 373
2024
Q1 		$97.2K Buy
717
+321
+81% +$42.5K 0.01% 452
2023
Q4 		$53.3K Buy
396
+208
+111% +$27K 0.01% 557
2023
Q3 		$25.4K Buy
188
+10
+6% +$1.37K ﹤0.01% 656
2023
Q2 		$25.5K Buy
178
+5
+3% +$736 ﹤0.01% 856
2023
Q1 		$24K Hold
173
– – ﹤0.01% 881
2022
Q4 		$23.5K Sell
173
-2
-1% -$251 ﹤0.01% 872
2022
Q3 		$19K Hold
175
– – ﹤0.01% 917
2022
Q2 		$23K Hold
175
– – ﹤0.01% 877
2022
Q1 		$23K Hold
175
– – ﹤0.01% 908
2021
Q4 		$20K Buy
175
+2
+1% +$235 ﹤0.01% 928
2021
Q3 		$21K Hold
173
– – ﹤0.01% 929
2021
Q2 		$21K Hold
173
– – ﹤0.01% 890
2021
Q1 		$17K Hold
173
– – ﹤0.01% 898
2020
Q4 		$17K Buy
173
+55
+47% +$5.83K ﹤0.01% 848
2020
Q3 		$13K Hold
118
– – ﹤0.01% 813
2020
Q2 		$12K Hold
118
– – ﹤0.01% 743
2020
Q1 		$11K Hold
118
– – ﹤0.01% 712
2019
Q4 		$12K Buy
+118
New +$11.1K ﹤0.01% 604

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Harbor Investment Advisory's AZN Position: Q2 2026 in Review

Harbor Investment Advisory increased its AstraZeneca (AZN) stake by 17% in Q2 2026, buying an estimated $49.3K and bringing the position to 1,766 shares worth $330K. The position accounts for 0.02% of the portfolio, ranked #349.

Harbor Investment Advisory first reported a position in AZN in Q4 2019 and has held it in 27 quarters since. 534 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Harbor Investment Advisory held 1,766 shares of AstraZeneca worth $330K as of Q2 2026.
  • Harbor Investment Advisory bought 262 AstraZeneca shares in Q2 2026, an estimated $49.3K.
  • AstraZeneca made up 0.02% of Harbor Investment Advisory's portfolio in Q2 2026, its #349 holding.
  • Harbor Investment Advisory first reported a position in AstraZeneca in Q4 2019 and has held it in 27 quarters since.
  • 534 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.